MTX1 and atherosclerosis: Regarding the analogy between Mtx, a conventional synthetic disease-modifying antirheumatic drug (DMARD), and Ifx, a biologic DMARD, we found that both drugs successfully decreased inflammation and oxidative stress markers in both types of animals, suggesting that these drugs could prevent the early onset of atherosclerosis.